JP2021531834A5 - - Google Patents

Info

Publication number
JP2021531834A5
JP2021531834A5 JP2021529507A JP2021529507A JP2021531834A5 JP 2021531834 A5 JP2021531834 A5 JP 2021531834A5 JP 2021529507 A JP2021529507 A JP 2021529507A JP 2021529507 A JP2021529507 A JP 2021529507A JP 2021531834 A5 JP2021531834 A5 JP 2021531834A5
Authority
JP
Japan
Prior art keywords
tcr
amino acid
seq
chain
exon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021529507A
Other languages
English (en)
Japanese (ja)
Other versions
JP7429455B2 (ja
JP2021531834A (ja
Filing date
Publication date
Priority claimed from CN201810854117.4A external-priority patent/CN110776562B/zh
Application filed filed Critical
Publication of JP2021531834A publication Critical patent/JP2021531834A/ja
Publication of JP2021531834A5 publication Critical patent/JP2021531834A5/ja
Application granted granted Critical
Publication of JP7429455B2 publication Critical patent/JP7429455B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021529507A 2018-07-30 2019-07-29 Afp抗原を識別するt細胞受容体 Active JP7429455B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810854117.4 2018-07-30
CN201810854117.4A CN110776562B (zh) 2018-07-30 2018-07-30 一种识别afp抗原的t细胞受体
PCT/CN2019/098245 WO2020024915A1 (zh) 2018-07-30 2019-07-29 一种识别afp抗原的t细胞受体

Publications (3)

Publication Number Publication Date
JP2021531834A JP2021531834A (ja) 2021-11-25
JP2021531834A5 true JP2021531834A5 (enExample) 2022-08-04
JP7429455B2 JP7429455B2 (ja) 2024-02-08

Family

ID=69232312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021529507A Active JP7429455B2 (ja) 2018-07-30 2019-07-29 Afp抗原を識別するt細胞受容体

Country Status (6)

Country Link
US (1) US12152065B2 (enExample)
EP (1) EP3831845A4 (enExample)
JP (1) JP7429455B2 (enExample)
CN (1) CN110776562B (enExample)
CA (1) CA3108466A1 (enExample)
WO (1) WO2020024915A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111662374B (zh) * 2019-03-08 2023-01-24 香雪生命科学技术(广东)有限公司 一种识别afp抗原的高亲和力tcr
EP4103284A1 (en) * 2020-02-14 2022-12-21 Adaptimmune Limited Method of treatment of cancer or tumour
CN113321727B (zh) * 2020-02-28 2024-04-09 香雪生命科学技术(广东)有限公司 一种识别afp抗原短肽的t细胞受体及其编码序列
CN113493505A (zh) * 2020-03-20 2021-10-12 香雪生命科学技术(广东)有限公司 识别afp抗原的高亲和力tcr
CN114057864B (zh) * 2020-07-30 2023-12-15 香雪生命科学技术(广东)有限公司 一种识别afp的高亲和力tcr
CN117460744A (zh) * 2021-05-31 2024-01-26 南京传奇生物科技有限公司 靶向afp肽/mhc复合物的抗体及其用途
JP7210677B1 (ja) * 2021-10-20 2023-01-23 デンカ株式会社 非水硬性セメント組成物及びセメント系材料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014301777B2 (en) * 2013-06-26 2017-03-30 Xlifesc, Ltd. High-stability T-cell receptor and preparation method and application thereof
GB201313377D0 (en) * 2013-07-26 2013-09-11 Adaptimmune Ltd T cell receptors
CN104087592B (zh) * 2014-05-13 2016-01-27 天津医科大学总医院 Afp158-166特异性tcr基因及其转基因t细胞及体外增殖方法及用途
WO2016161390A1 (en) * 2015-04-03 2016-10-06 Eureka Therapeutics, Inc. Constructs targeting afp peptide/mhc complexes and uses thereof
CA2988397A1 (en) * 2015-05-08 2016-11-17 Eureka Therapeutics, Inc. Constructs targeting hpv16-e7 peptide/mhc complexes and uses thereof
HK1248255A1 (zh) * 2015-06-24 2018-10-12 优瑞科生物技术公司 靶向ny-eso-1肽/mhc复合物的构建体及其用途
GB201520575D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
CN105524884A (zh) * 2016-02-29 2016-04-27 时宏珍 Hla-a0201限制性抗afp抗原特异性ctl的制备方法
WO2018208553A1 (en) * 2017-05-12 2018-11-15 Augusta University Research Institute, Inc. Human alpha fetoprotein-specific t cell receptors and uses thereof
CN111662374B (zh) * 2019-03-08 2023-01-24 香雪生命科学技术(广东)有限公司 一种识别afp抗原的高亲和力tcr

Similar Documents

Publication Publication Date Title
JP2022502056A5 (enExample)
JP2021531834A5 (enExample)
TWI817302B (zh) 改良的雙特異性多肽分子
HRP20230542T1 (hr) T stanični receptori
JP2021520198A5 (enExample)
JP2018504092A5 (enExample)
RU2016101711A (ru) Высокостабильный т-клеточный рецептор и способ его получения и применения
HRP20220865T1 (hr) T stanični receptori
JP2023139070A5 (enExample)
JP2022527635A5 (enExample)
HRP20221021T1 (hr) T stanični receptori specifični za kompleks tumorskog antigena ny-eso-1 sa hla-a*02
JP2021511826A5 (enExample)
JP2019137675A5 (enExample)
JP2021533779A (ja) 操作された二重特異性タンパク質
JP2017527272A5 (enExample)
JP2020501550A5 (enExample)
CN113195530B (zh) 抗体融合蛋白、制备方法及其应用
TW201245228A (en) Fusion proteins for HIV therapy
JP2023522799A5 (enExample)
JP2023524788A5 (enExample)
JP2022547837A5 (enExample)
WO2019196309A1 (zh) 抗pd-l1抗体及其用途
JP2023518293A5 (enExample)
CN106336457B (zh) 识别mage‑a3抗原短肽的t细胞受体
JP2018522061A5 (enExample)